Company 2cureX AB (publ) Nasdaq Stockholm
Equities
SE0010468124
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 21-01-31 | |
Grith Hagel
FOU | Founder | 65 | 05-12-31 |
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Raphael Gruber
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-06-30 |
Jacob Thastrup
PRN | Corporate Officer/Principal | - | - |
Tabea Sturmheti
PRN | Corporate Officer/Principal | 39 | 16-12-31 |
Corporate Officer/Principal | 59 | 21-07-31 | |
Manuel Fernández
LAW | General Counsel | - | 22-04-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Chairman | - | Nov. 13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,602,916 | 7,467,585 ( 42.42 %) | 0 | 42.42 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-14.52% | 11.53B | |
+44.03% | 3.31B | |
-33.09% | 2.11B | |
-18.60% | 2.05B | |
-27.59% | 1.49B | |
+17.10% | 1.02B | |
-3.06% | 741M | |
-33.50% | 426M | |
-46.94% | 374M |